Vancouver, British Columbia–(Newsfile Corp. – November 11, 2020) – GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) (“GreenStar” or the “Company“) announces today it will be seeking approval of the Canadian Securities Exchange (the “CSE“) to change its name from GreenStar Biosciences Corp. to Lobe Sciences Ltd. and change its CSE ticker symbol to “LOBE” (the “Name and Symbol Change“). There is no change of business associated with, or being effected with respect to, the Name and Symbol Change. Subject to receipt of the approval of the CSE, is expected that the Company’s common shares will commence trading on the CSE under the new name and symbol on or about November 16, 2020 (the “Effective Date“).
The Company’s new CUSIP and ISIN numbers will be 53946V107 and CA53946V1076, respectively. Shares normally commence trading under the new name and symbol at the opening of trading two or three trading days after the filing of necessary documents. No action will be required by existing shareholders with respect to the Name and Symbol Change.
GreenStar is a growth-oriented technology & services company that provides real estate, financial, management, IP & branding support to businesses. The Company operates a growing portfolio of tenant partner companies focused on developing transformational medicines and applies refined strategies to help partner companies reach their full potential. Based in Vancouver, BC, GreenStar intends to facilitate growth through acquisitions and development of additional assets, products and technologies by leveraging its capital markets, branding and operational expertise.
For further information please contact:
GreenStar Biosciences Corp.
Thomas Baird, CEO
Tel: (949) 505-5623
THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.
Disclaimer for Forward Looking Statements
This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact, included in this release, including statements regarding the Effective Date are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations are risks detailed from time to time in the filings made by the Company with securities regulations. Readers are cautioned that assumptions used in the preparation of the forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks and uncertainties, including any delay in obtaining approval of the CSE for the Name and Symbol Change, or otherwise; changes to the regulatory environment; and other changes beyond the Company’s control. As a result, the Company cannot guarantee that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made only as of the date of this news release and the Company does not intend to update any of the included forward-looking statements except as expressly required by applicable Canadian securities laws.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/68014